Fevia Diarrhea Control Capsule, Liquid Filled
Product Images NDC 82706-028

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Fevia Diarrhea Control (NDC 82706-028). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Vivunt Pharma Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

Pdp1 (Editable Box Fevia Bismuth 262 mg X 24 Softgels 001)

Pdp1 (Editable Box Fevia Bismuth 262 mg X 24 Softgels 001)
This is a drug label for an antidiarrheal product containing Bismuth Subsalicylate 262 mg. It is sugar-free and helps relieve travelers' diarrhea, upset stomach, heartburn, indigestion, nausea, gas, and belching. The label includes information on dosage, warnings, directions for use, and inactive ingredients. It also provides caution against use in certain conditions and situations, and advises consulting a doctor in case of specific symptoms or conditions. Distributed by Vivunt Pharma LLC in Miami, USA, the product is from India.*
FDA Label Image

Bottle (Label Fevia Bismuth 262 mg X 24 Softgels 001)

Bottle (Label Fevia Bismuth 262 mg X 24 Softgels 001)
This text provides information about Lulciet Diarrhea Control, a product containing Bismuth Subsalicylate 262mg. It mentions the relief of symptoms such as diarrhea, upset stomach, heartburn, indigestion, nausea, and bloating. The use of the product is cautioned for individuals with certain health conditions like bleeding disorders, kidney problems, or allergies to salicylate. It also advises consulting a doctor before use in cases of certain medical conditions like diabetes, blood thinning, or gout. The recommended dosage for adults and children over 12 years old is provided, along with instructions to seek medical attention if symptoms worsen or last more than 2 days. Additionally, the text includes information about inactive ingredients and a contact number for further questions.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.